Gabapentin is a controlled substance in states like Michigan and Kentucky, while others have mandated reporting rules. Learn about its risk for abuse here. The number of states placing gabapentin on the controlled substance list or in their required monitoring program is growing and three more states are debating whether to add gabapentin as a controlled substance or to their mandated reporting programs (DE, NY, and WI). There have been increasing reports of gabapentin misuse, either alone or with opioids to enhance their euphoric (“high”) effects. At the federal level, gabapentin is not a controlled substance. However, some states have implemented their laws to reclassify gabapentin as a Schedule V controlled substance. Individuals at the highest risk for abusing gabapentin include those with opioid abuse, mental illness, or previous history of prescription drug abuse. States are now taking action to track gabapentin use through prescription monitoring programs, and some states have reclassified it as a Schedule V controlled substance. Gabapentin, originally developed to treat epilepsy, has gained popularity as a medication for neuropathic pain and other conditions. However, its increasing use has raised concerns about potential misuse and addiction. As a result, various states have begun to classify gabapentin as a controlled substance. Understanding the legal status of gabapentin across different jurisdictions is crucial Gabapentin isn't a narcotic, but it is a controlled substance in some states. Here's what you should know before using it. Regional Variation Gabapentin’s regulatory status varies by state. Some states classify it as a Schedule V controlled substance due to concerns about misuse and its involvement in the opioid crisis. Others do not schedule it but require mandatory reporting to state prescription drug monitoring programs (PDMPs) to track prescribing and dispensing. Presently, seven states have classified gabapentin as a Schedule V controlled substance, and 12 others, New Jersey included, require that gabapentin prescriptions be reported in the PDMP system. Every time a prescription for gabapentin is filled out, it will automatically be added to the database. Introduction: Gabapentin is a prescription medication approved by the United States Food and Drug Administration (FDA) for the treatment of neuropathic pain and epileptic disorders. This drug is currently marketed in capsule, tablet, and oral solution formulations. In recent years, however, gabapentin has been increasingly encountered by law enforcement, documented in national crime lab Individuals at the highest risk for abusing gabapentin include those with opioid abuse, mental illness, or previous history of prescription drug abuse. States are now taking action to track gabapentin use through prescription monitoring programs, and some states have reclassified it as a Schedule V controlled substance. Michigan joins a growing number of states that have scheduled Gabapentin as a controlled substance. “Using a data-driven approach, we identified Gabapentin as an emerging threat in our state and took necessary action to protect Michigan residents,” said LARA Director Orlene Hawks. Gabapentin is a prescription medication approved by the FDA for the treatment of neuropathic pain (postherpetic neuralgia) and seizure disorders. Why is gabapentin controlled in some states? Gabapentin is structurally and pharmacologically related to pregabalin (Lyrica, Lyrica CR), which is a Schedule V drug and controlled federally in all states. Gabapentin is used to treat many conditions, including seizures and pain conditions. Gabapentin is not a controlled substance on a federal level but is controlled in some states, which limits the number of prescription refills and how it is reported. Gabapentin can be dangerous when used in combination with other substances, particularly opioids. The FDA approved gabapentin in 1993 as a non-controlled substance and it has remained a non-controlled substance at the federal level. The drug was created as an anticonvulsant and used to treat seizure disorders. The medication has also been used to treat hot flashes, neuropathic pain, pain, postoperative nausea, substance abuse issues, and vomiting. 1,2 It is estimated that approximately 1% As of June 2024, gabapentin remains a non-controlled substance under the U.S. federal government. With mounting evidence of misuse and abuse of gabapentin use, certain states have implemented regulations or policies to limit or monitor the use of the drug, especially given its potential to enhance the effects of opioids. We would like to show you a description here but the site won’t allow us. There have been increasing reports of gabapentin misuse, either alone or with opioids to enhance their euphoric (“high”) effects. At the federal level, gabapentin is not a controlled substance. However, some states have implemented their laws to reclassify gabapentin as a Schedule V controlled substance. Individuals at the highest risk for abusing gabapentin include those with opioid abuse, mental illness, or previous history of prescription drug abuse. States are now taking action to track gabapentin use through prescription monitoring programs, and some states have reclassified it as a Schedule V controlled substance. Gabapentin is a Schedule V drug in states where it’s classified as a controlled substance. Despite its increasing use, especially for off-label purposes, gabapentin typically does not have the same potential for misuse or dependence as some other drugs, such as opioids or benzodiazepines. Presently, seven states have classified gabapentin as a Schedule V controlled substance, and 12 others, New Jersey included, require that gabapentin prescriptions be reported in the PDMP system. Every time a prescription for gabapentin is filled out, it will automatically be added to the database.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | |
![]() | ![]() |
![]() | ![]() |